ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The year psychedelics went mainstream"
Episode Synopsis
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022.
Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major research trend that flew under the radar this year: increased public and private funding for trials looking into therapeutic psychedelics.
Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major research trend that flew under the radar this year: increased public and private funding for trials looking into therapeutic psychedelics.
More episodes of the podcast Axios Re:Cap
2021's challenges for journalism
22/12/2021
Biden's big immigration challenges
20/12/2021
Reflecting on our second year of COVID
17/12/2021
A big year for blockchain
16/12/2021
The shortage economy of 2021
16/12/2021
The great space race of 2021
15/12/2021
Covering Washington in 2021
14/12/2021
In God we trust